(Q42837744)

8 November 2017

title

Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugs (English)

1 reference

8 November 2017

5

1 reference

8 November 2017

7

1 reference

8 November 2017

Philippe Garnier

1

1 reference

8 November 2017

Xiang-Tao Wang

2

1 reference

8 November 2017

Mark A Robinson

3

1 reference

8 November 2017

Sander van Kasteren

4

1 reference

8 November 2017

Malcolm Frier

6

1 reference

8 November 2017

Benjamin G Davis

8

1 reference

8 November 2017

publication date

1 December 2010

1 reference

Journal of Drug Targeting

8 November 2017

published in

1 reference

8 November 2017

volume

18

1 reference

8 November 2017

issue

10

1 reference

8 November 2017

page(s)

794-802

1 reference

Adriamycin. A new anticancer drug with significant clinical activity

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Asialoglycoprotein receptor in human isolated hepatocytes from normal liver and its apparent increase in liver with histological alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Glycoprotein synthesis: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Capecitabine: a novel agent for the treatment of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

A clinicopathologic analysis of adriamycin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Elucidation of the structure of the Pasteurella haemolytica serotype T10 lipopolysaccharide O-antigen by n.m.r. spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

LEAPT: lectin-directed enzyme-activated prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Site-selective chemical protein glycosylation protects from autolysis and proteolytic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Recent trends in targeted anticancer prodrug and conjugate design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Cell biology of liver endothelial and Kupffer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Biological roles of oligosaccharides: all of the theories are correct

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Structural basis of lectin-carbohydrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

Strategies in developing promising histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.529909

10.3109/1061186X.2010.529909

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference